Michael Mithoefer, Lisa Jerome, Richard Doblin. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AnimalsBrain/drug effectsBrain/metabolismDopamine/metabolismDopamine Plasma Membrane Transport ProteinsHallucinogens/administration & dosageHallucinogens/adverse effectsHallucinogens/toxicityHaplorhiniHumansMembrane GlycoproteinsMembrane Transport Proteins/metabolismN-Methyl-3,4-methylenedioxyamphetamine/administration & dosageN-Methyl-3,4-methylenedioxyamphetamine/adverse effectsN-Methyl-3,4-methylenedioxyamphetamine/toxicityNerve Tissue ProteinsNeurons/drug effectsNeurons/metabolismParkinsonian Disorders/chemically induced
Substances: See more » Dopamine Plasma Membrane Transport ProteinsHallucinogensMembrane GlycoproteinsMembrane Transport ProteinsNerve Tissue ProteinsN-Methyl-3,4-methylenedioxyamphetamineDopamine
Year: 2003 PMID: 12791964 DOI: 10.1126/science.300.5625.1504
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728